Instem proves in step with
groundbreaking market needs as it
posts strong 2022 performance

Proactive interview with Phil Reason,
Instem CEO

Investor Meet Company: Results and Company Update
September 2022

Presentation now available to watch on-demand

Watch Now

A global provider of leading software solutions
and services to the life sciences community.

The future transformed for the benefit of everyone.
Intelligent solutions empowering collaboration and life-enhancing science.

Learn more

Creating a more connected ecosystem in the
life sciences industry by consolidating and
harmonizing a fragmented IT marketplace.

Learn more

Welcome to the Instem Investor Centre

Instem (AIM:INS.L) is a leading provider of IT solutions and services to the global early development healthcare market, delivering compelling solutions for data collection, analysis and regulatory submissions management.



Latest News

25 September 2023 - Publication of Scheme Document

Read More

19 September 2023 - Grant of PDMR Options

Read More

15 September 2023 - Half Year Report

Read More

Annual Report 2022

H1 23 – another strong trading performance

Annual Report 2022

H1 23 – another strong trading performance

Research Note by Gareth Evans of Progressive Equity Research